Financial Ratios

DR AGARWALS EYE HOSPITAL LTD.

NSE : NABSE : 526783ISIN CODE : INE934C01018Industry : Hospital & Healthcare ServicesHouse : Private
BSE3282.0030.7 (+0.94 %)
PREV CLOSE ( ) 3251.30
OPEN PRICE ( ) 3166.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 749
TODAY'S LOW / HIGH ( )3166.00 3350.00
52 WK LOW / HIGH ( ) 1056.053550
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)78.5551.28-3.0629.1125.35
   CEPS(Rs)121.4994.6637.5874.2948.57
   DPS(Rs)3.003.000.000.001.50
   Book NAV/Share(Rs)241.15166.32116.30119.3697.00
   Tax Rate(%)25.2625.41125.0931.3831.62
Margin Ratios
   Core EBITDA Margin(%)28.2129.1521.3526.7817.63
   EBIT Margin(%)21.4419.649.0816.2112.37
   Pre Tax Margin(%)18.4416.064.1011.3310.25
   PAT Margin (%)13.7811.98-1.037.787.01
   Cash Profit Margin (%)21.3122.1112.6319.8513.42
Performance Ratios
   ROA(%)9.789.63-0.869.5511.01
   ROE(%)38.5636.29-2.6026.9129.55
   ROCE(%)42.9842.4016.9239.8734.30
   Asset Turnover(x)0.710.800.841.231.57
   Sales/Fixed Asset(x)0.810.890.951.632.68
   Working Capital/Sales(x)-5.37-6.24-5.32-18.14-31.03
Efficiency Ratios
   Fixed Capital/Sales(x)1.231.131.060.610.37
   Receivable days12.7915.8320.3015.9816.86
   Inventory Days7.999.9317.2215.0114.84
   Payable days320.55347.24351.93238.56312.99
Valuation Parameters
   PER(x)11.6514.260.006.5614.33
   PCE(x)7.537.728.332.577.48
   Price/Book(x)3.804.392.691.603.75
   Yield(%)0.330.410.000.000.41
   EV/Net Sales(x)1.661.721.050.571.12
   EV/Core EBITDA(x)5.745.794.612.025.94
   EV/EBIT(x)7.768.7711.553.529.01
   EV/CE(x)1.061.040.880.601.58
   M Cap / Sales1.611.711.050.511.00
Growth Ratio
   Net Sales Growth(%)33.1443.92-20.543.4710.91
   Core EBITDA Growth(%)29.5688.44-36.1255.7420.36
   EBIT Growth(%)45.34211.36-55.5135.5925.49
   PAT Growth(%)53.201775.24-110.5114.8475.87
   EPS Growth(%)53.201775.24-110.5114.8475.87
Financial Stability Ratios
   Total Debt/Equity(x)0.390.410.400.310.52
   Current Ratio(x)0.480.610.630.750.84
   Quick Ratio(x)0.420.540.550.550.66
   Interest Cover(x)7.145.481.823.325.82
   Total Debt/Mcap(x)0.100.090.150.200.14

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.